title: Is the tolerability of long-term thiazolidinedione therapy overstated?
authors.forename: Robb M
authors.initials: RM
authors.lastname: Malone
authors.forename: Darren A
authors.initials: DA
authors.lastname: DeWalt
authors.forename: Mike P
authors.initials: MP
authors.lastname: Pignone
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Ives
mesh_terms: D015986:Confounding Factors, Epidemiologic; D048909:Diabetes Complications; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008137:Longitudinal Studies; D013844:Thiazoles / Q000008:administration & dosage* / Q000009:adverse effects; D045162:Thiazolidinediones
chemical_list: D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; C089946:2,4-thiazolidinedione